As the treatment landscape for cervical cancer rapidly evolves with recent approvals of immuno-oncology agents and ongoing evaluation of emerging therapies, it is critical to stay current on the latest approvals, clinical efficacy and safety, biomarker indications, and patient-centric care strategies. In this interactive Clinical Case Challenge: apply your clinical reasoning skills to a real-world patient simulation test your skills in distinguishing between new and emerging immune-oncology agents and integrating biomarker testing results into patient-centric treatment and management plans see how well you do relative to other healthcare professionals access a downloadable summary of key supporting evidence. This activity is delivered in partnership with The National Cervical Cancer Coalition (NCCC).
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/evidence-based-cervical-cancer-screening-treatment-management-vulnerable-high
- Start Date: 2024-06-28 05:00:00
- End Date: 2024-06-28 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Merck (Any division) - Amount: 46500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology